1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Arnalich-Montiel F, Lorenzo-Morales J, Irigoyen C, Morcillo-Laiz R, López-Vélez R, Muñoz-Negrete F, Piñero JE, Valladares B.

    Co-isolation of Vahlkampfia and Acanthamoeba in Acanthamoeba-Like Keratitis in a Spanish Population

    CORNEA . 32(5): 608-614. Nº de citas: 20

    [doi:10.1097/ICO.0b013e31825697e6]

  • Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J.

    Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain

    HIV MEDICINE . 14(5): 273-283. Nº de citas: 47

    [doi:10.1111/hiv.12001]

  • Cobo J, Lora-Tamayo J, Euba G, Jover-Sáenz A, Palomino J, del Toro MD, Rodríguez-Pardo D, Riera M, Ariza J.

    Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria

    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 76(1): 93-98. Nº de citas: 11

    [doi:10.1016/j.diagmicrobio.2013.02.019]

  • Suárez-García I, Jarrín I, Iribarren JA, López-Cortés LF, Lacruz-Rodrigo J, Masiá M, Gómez-Sirvent JL, Hernández-Quero J, Vidal F, Alejos-Ferreras B, Moreno S, Del Amo J.

    Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 31(5): 304-312. Nº de citas: 8

    [doi:10.1016/j.eimc.2012.03.009]

  • van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chêne G, Dorrucci M, Muga R, Porter K, Prins M.

    Effect of HCV Infection on Cause-Specific Mortality After HIV Seroconversion, Before and After 1997

    Gastroenterology . 144(4): 751-751. Nº de citas: 77

    [doi:10.1053/j.gastro.2012.12.026]

  • McCarthy AE, Weld LH, Barnett ED, So H, Coyle C, Greenaway C, Stauffer W, Leder K, Lopez-Velez R, Gautret P, Castelli F, Jenks N, Walker PF, Loutan L, Cetron M.

    Spectrum of Illness in International Migrants Seen at GeoSentinel Clinics in 1997-2009, Part 2: Migrants Resettled Internationally and Evaluated for Specific Health Concerns

    CLINICAL INFECTIOUS DISEASES . 56(7): 925-933. Nº de citas: 73

    [doi:10.1093/cid/cis1016]

  • Navarro-San Francisco C, Del Toro MD, Cobo J, De Gea-García JH, Vañó-Galván S, Moreno-Ramos F, Rodríguez-Baño J, Paño-Pardo JR.

    Knowledge and perceptions of junior and senior Spanish resident doctors about antibiotic use and resistance: Results of a multicenter survey

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 31(4): 199-204. Nº de citas: 56

    [doi:10.1016/j.eimc.2012.05.016]

  • Mocroft A, Phillips AN, Gatell J, Horban A, Ledergerber B, Zilmer K, Jevtovic D, Maltez F, Podlekareva D, Lundgren JD.

    CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use

    AIDS . 27(6): 907-918. Nº de citas: 13

    [doi:10.1097/QAD.0b013e32835cb766]

  • Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K, CASCADE collaboration in EuroCoord.

    Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts

    CLINICAL INFECTIOUS DISEASES . 56(6): 888-897. Nº de citas: 87

    [doi:10.1093/cid/cis1000]

  • Lodi S, del Amo J, d'Arminio Monforte A, Abgrall S, Sabin C, Morrison C, Furrer H, Muga R, Porter K, Girardi E.

    Risk of tuberculosis following HIV seroconversion in high-income countries

    Thorax . 68(3): 207-213. Nº de citas: 26

    [doi:10.1136/thoraxjnl-2012-201740]

  • Casado JL, de la Calle C, del Palacio M, Perez-Elías MJ, Moreno A, Moreno S.

    Short Communication Lamivudine Plus a Boosted-Protease Inhibitor as Simplification Strategy in HIV-Infected Patients: Proof of Concept

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 29(3): 588-591. Nº de citas: 6

    [doi:10.1089/aid.2012.0280]

  • van Griensven J, Diro E, Lopez-Velez R, Boelaert M, Lynen L, Zijlstra E, Dujardin JC, Hailu A.

    HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals

    LANCET INFECTIOUS DISEASES . 13(3): 251-259. Nº de citas: 33

    [doi:10.1016/S1473-3099(12)70348-1]

  • Fortún J, Centella T, Martín-Dávila P, Lamas MJ, Pérez-Caballero C, Fernández-Pineda L, Otheo E, Cobo J, Navas E, Pintado V, Loza E, Moreno S.

    Infective endocarditis in congenital heart disease: a frequent community-acquired complication

    INFECTION . 41(1): 167-174. Nº de citas: 37

    [doi:10.1007/s15010-012-0326-6]

  • Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sánchez-Somolinos M, Baraia-Etxaburu JM, Rico A, Palomino J, Rodríguez-Pardo D, Horcajada JP, Benito N, Bahamonde A, Granados A, del Toro MD, Cobo J, Riera M, Ramos A, Jover-Sáenz A, Ariza J.

    A Large Multicenter Study of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention

    CLINICAL INFECTIOUS DISEASES . 56(2): 182-194. Nº de citas: 307

    [doi:10.1093/cid/cis746]

  • Anta L, Llibre JM, Poveda E, Blanco JL, Alvarez M, Pérez-Elías MJ, Aguilera A, Caballero E, Soriano V, de Mendoza C.

    Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS . 27(1): 81-85. Nº de citas: 50

    [doi:10.1097/QAD.0b013e3283584500]

  • Serrano-Villar S, Gutiérrez C, Vallejo A, Hernández-Novoa B, Díaz L, Abad Fernández M, Madrid N, Dronda F, Zamora J, Muñoz-Fernández MÁ, Moreno S.

    The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression

    JOURNAL OF INFECTION . 66(1): 57-66. Nº de citas: 130

    [doi:10.1016/j.jinf.2012.09.013]

  • Gutiérrez C, Hernández-Novoa B, Pérez-Elías MJ, Moreno AM, Holguín A, Dronda F, Casado JL, Moreno S.

    Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

    HIV CLINICAL TRIALS . 14(1): 10-16.

    [doi:10.1310/hct1401-10]

  • Casado JL, de Los Santos I, Del Palacio M, García-Fraile L, Pérez-Elías MJ, Sanz J, Moreno S.

    Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.

    HIV CLINICAL TRIALS . 14(1): 1-9.

    [doi:10.1310/hct1401-1]